Embryology: PGT-M readiness, a media recall and warming authorization
A missing family sample, a culture-media recall and an embryo that doesn't survive warming, each traced to the exact embryo, case and decision.
Product preview · Fictional patient data
For embryology & lab
Lab work depends on exact identity: the right specimen, the right report, the right embryo. OvaFlow keeps the follow-up visible and hands every check to your lab's electronic witnessing and lab systems.
Exact-embryo authorization. If a warmed embryo doesn't survive, another one is not warmed without a new authorization.
Who this is for
Embryologists, lab directors, andrology, genetics (PGT) coordinators and cryobank managers.
One embryo, four checks
Culture, biopsy, genetic testing and warming. At each step OvaFlow keeps the follow-up and its owner in view, and hands the check itself to your lab's own systems.
Media lot recalls traced through paper binders.
Lot-recall investigations with a named reviewer for every case and lab-director closure.
Specimen and biopsy label mismatches.
Label and barcode stops that hand off to your lab's electronic witnessing system.
A missing family sample or a change of genetics lab leaves PGT-M unready.
A PGT-M critical path with lab acceptance and family samples tracked.
A second embryo warmed automatically after one doesn't survive warming.
Exact-embryo warming authorization, and a new decision if an embryo doesn't survive warming.
A shift with OvaFlow
Drawn from the prototype walkthroughs. Times are from the fictional demonstration day.
Embryology, andrology, PGT coordination, and cryobank teams track every dish, biopsy tube, culture-media lot, warming order, and storage cane across strict chain-of-custody boundaries. ASRM laboratory operations, PGT-M, and cryostorage guidelines—alongside historical FDA Class 2 recalls of IVF culture and sperm-wash media—show why specimen lineage, exact-embryo warming authorization, and lab-director review cannot live in disconnected paper binders [1, 2, 3, 4, 5].
Genetics lab acceptance and family cheek-swab / blood reference samples
Stimulation starts before a missing family reference sample arrives, or a lab switch assumes amplified biopsy DNA can transfer.
PGT-M critical-path board shows missing family sample holding cycle start and blocks cross-lab DNA assumptions
Hold visible · Family sample requiredSemen sample barcode and trophectoderm biopsy tube labels (Biopsy A vs. Re-biopsy B)
A duplicate andrology barcode or a second biopsy overwriting the first biopsy record causes an accession hold.
Flags label/barcode discrepancy and hands off directly to the lab's own electronic or two-person witnessing process
Stopped · Handed to lab witness checkClinician-signed FET warming authorization for Embryo #2 only
If Embryo #2 does not survive warming, an ambiguous standing note leads to warming Embryo #3 without a fresh decision.
Authorizes Embryo #2 only; if it does not survive warming, Embryo #1 and #3 lock until a new signed decision
Single-embryo lock · New decision requiredUrgent lot notice for culture or sperm-wash media batch used across 3 dishes
Tracing which embryos touched a recalled lot requires flipping through paper dish logs across multiple incubators.
Lists every affected dish-use record, assigns a named reviewer per case, and requires Lab Director closure
3 cases assigned · Lab Director gateIncoming dry-shipper courier or tank telemetry alert
Quarantined shipping clearance is mistaken for clinical-use release, or emergency relocation moves canes without confirmed capacity.
Tracks shipping release separately from clinical-use clearance and requires receiving-lab capacity acceptance
Verified item-by-item · Capacity acceptedWorked laboratory case · Jordan Patel & Alex Chen (Embryology & Cryo)
Follow Senior Embryologist Jordan Patel and Lab Coordinator Alex Chen through four high-consequence laboratory coordination moments: a PGT-M family sample hold, biopsy A/B lineage, a culture-media lot recall investigation, and an exact-embryo warming stop.
Why this moment matters in an IVF clinic
ASRM guidance notes that PGT-M test development can take weeks to months and amplified biopsy DNA cannot simply be moved to a new genetics lab [2]. Meanwhile, FDA Class 2 recalls of ART media lots in 2023–2024 proved that labs need rapid, auditable lot-to-dish tracing with named clinical and laboratory sign-off [4, 5].
On the PGT-M critical path, a missing family reference sample is shown as the exact blocker holding stimulation readiness. Once embryos reach the blastocyst stage, trophectoderm Biopsy A and any subsequent Re-biopsy B are preserved as distinct child records—never overwriting earlier genetics results or hiding an amended PGT report before transfer planning.[1][2]
When an andrology container barcode or biopsy tube label shows a collision, OvaFlow raises a hard stop and routes the check to the laboratory's own electronic or dual-witnessing system. OvaFlow never acts as or replaces the witness system.[1]
Warming is authorized specifically for Embryo #2. When Embryo #2 does not survive warming, OvaFlow blocks any automatic progression to Embryo #1 or Embryo #3 and opens a new clinician-and-patient decision workflow.[1]
When a manufacturer lot notice arrives for a culture medium, OvaFlow surfaces the three exposed dish records, assigns a named reviewer to each, and holds closure for the Lab Director. In the cryobank, quarantined transport clearance stays distinct from clinical-use release, and emergency tank relocation requires explicit capacity acceptance by the receiving lab.[3][4][5]
Any label or barcode mismatch stops and hands off to the lab's own witnessing system. If the authorized embryo does not survive warming, remaining embryos stay locked until a new decision is recorded.
Lab, cryostorage, and long-term continuity come in a later phase. OvaFlow never ranks embryos, replaces bench witnessing, or serves as the primary tank inventory.
How OvaFlow tracks pre-cycle genetic test setup, biopsy records, media lot follow-up, and warming authorization for one specific embryo.
Prototype walkthroughs
Recorded from the interactive design prototype with fictional patient data. Open one to play it here with chapters and captions.
Shipping clearance isn't clinical clearance, a bounced email isn't abandonment, and a model update waits for the medical director.
Accession holds, amended PGT reports, cryo tank signals and pharmacy change requests land in one queue, each with a named owner.
From duplicate barcodes to cold-chain delivery and the patient's own “received”, every handoff to the clinic's own system has an owner and a confirmation.
Common questions & sources
How OvaFlow handles edge cases, clinical authority, and source-system boundaries for this role.
Never. Physical and electronic witnessing stay entirely inside your laboratory's own witnessing system and SOPs. OvaFlow surfaces pre-procedure label or barcode discrepancies and hands the check off to qualified lab staff.[1]
Warming authorization in OvaFlow is tied to one exact embryo identifier. If that embryo does not survive warming, OvaFlow locks remaining stored embryos against automatic warming and opens an immediate decision handoff for the physician, embryologist, and patient.[1]
Next step
Walk through PGT-M readiness, multi-biopsy lineage, culture-media lot recall investigations, and exact-embryo warming safeguards.